REGINA TOAL: Open Payments
NPI 1003100652 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 11 payments from 6 companies in 2025. Trend: 2023 $504 · 2024 $262 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $174 |
| Novo Nordisk Inc | 3 | $129 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
| Dynavax Technologies Corporation | 2 | $50 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: FARXIGA, Da Vinci Surgical System, Ozempic, Heplisav-B, Wegovy, AIRSUPRA, Rybelsus, SHINGRIX.
Industry payments across MD — which companies pay providers there.
